Coronavirus vaccine gets positive results in first human trial New York Post Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial CNBCEarly study of Covid-19 vaccine developed in China sees mixed results STATEarly Coronavirus Immunity Data Fuel Promise for a Vaccine Scientific AmericanSafety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial The LancetView Full Coverage on Google News

BING NEWS:
  • Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
    Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer drug Keytruda.
    04/24/2024 - 11:31 pm | View Link
  • YS Biopharma reports positive interim data from rabies vaccine trial
    YS Biopharma has reported positive interim ... “The interim results of the pivotal Phase III trial provide compelling evidence of the robust immunogenicity and favourable safety profile of the PIKA ...
    04/10/2024 - 12:49 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News